One of Canada’s best-known independent financial services firms may be heading off the stock market, but the proposed purchase price tells only part of the story. Canaccord Genuity Group announced on November 15, 2026, that chairman and chief executive Dan Daviau had agreed to acquire the publicly held shares through a company he owns. The estimated consideration is C$15.27 per common share, based on a recent exchange rate, and the transaction is tied to a separate sale of Canaccord’s British wealth management operation.
Together, the agreements could reshape an international brokerage whose clients include individual investors, businesses and institutions. For shareholders, the opportunity is significant, but the cash has not been paid, the final Canadian-dollar amount can move, and several approvals still stand between an agreement and a completed takeover.
A CEO-Led Bid Could End Decades of Public Ownership
The proposed buyer is CG Acquisitionco Inc., a company wholly owned by Daviau. Under an arrangement agreement signed November 15, it would purchase the common shares not already held by Daviau or his affiliates. It would also acquire Canaccord’s outstanding Series C preferred shares. If the transaction closes, Canaccord’s common and Series C preferred shares are expected to disappear from the Toronto Stock Exchange, where the company currently trades under the symbol CF.
The distinction between a signed agreement and a completed purchase matters. Canaccord, whose origins date to 1950, operates across wealth management and capital markets in several countries. Its advisers still serve clients, bankers still work on deals and employees still report to the existing leadership. The proposal concerns ownership of the parent company rather than an immediate closure of its brokerage operations. Daviau and the current executive team are expected to continue running the business if the buyout succeeds.
The C$15.27 Price Comes With a Currency Catch
The estimated C$15.27 payout has two components. One is C$7.45 per common share for the business Canaccord would retain after selling its UK wealth division. The other is £4.15 per share, representing a portion of the anticipated proceeds from that sale. Using the pound-to-Canadian-dollar exchange rate on November 13, the sterling amount was worth approximately C$7.82, bringing the combined figure to C$15.27. Crucially, the sterling portion is expressed as a specified pound amount rather than another fixed Canadian-dollar payment.
That number is therefore a snapshot, not a guaranteed Canadian-dollar cheque. The company says the £4.15 will be converted into Canadian dollars when the transaction closes, with no currency hedge in place. For someone holding 100 common shares, the advertised estimate would equal C$1,527, but the final amount could be higher or lower as sterling moves. This is different from the Series C preferred-share offer, which is fixed at C$25.30 per share, plus accrued and unpaid dividends.
Selling the UK Wealth Business Is the Essential First Step
Before Daviau’s buyout can close, Canaccord must complete another large transaction. Affiliates of Centerbridge Partners and Mubadala Investment Company have agreed to acquire its UK and Crown Dependencies wealth management operations at an enterprise value of approximately £1.17 billion. Canaccord expects to receive about £564 million after relevant adjustments. Those figures differ because the parent company holds an estimated 66.9% equity-equivalent interest and other securities and closing adjustments affect the distribution of proceeds.
The British operation is substantial, not a peripheral division. It reported approximately C$81.7 billion, or £43.3 billion, in client assets at September 30, 2026. Under the proposed sale, management and employees would retain a meaningful ownership interest, and the business would continue using the Canaccord Wealth name under a two-year licence. Importantly, Canaccord’s UK capital markets arm is excluded from the sale. The UK wealth sale can proceed without Daviau’s buyout, but the buyout cannot proceed without the sale.
The Premium Depends on Which Share Price Is Used
Canaccord presents the proposed consideration as a 26.7% premium to the C$12.05 closing share price on February 13, 2026, before the company disclosed that it was assessing options for its UK wealth business. Against the 30-day volume-weighted average price through November 13, the premium is 7.8%. Both comparisons are accurate within their stated periods, but they describe different moments in a year when speculation about potential transactions had already influenced market expectations.
For a more immediate reference, Canaccord shares closed at C$14.79 on November 13. At the announced exchange-rate assumption, the proposed C$15.27 payout is only C$0.48 above that close, or about 3.2%. The company also argues that the C$7.45 attributed to the remaining business exceeds an estimated market-implied value of C$6.34 based on recent trading. Investors weighing the proposal will need to distinguish the value unlocked by the UK sale from the premium being offered for the operations Daviau wants to own.
Strong Quarterly Results Add an Interesting Twist
The transaction was unveiled alongside Canaccord’s second-quarter fiscal 2027 results, covering the three months ended September 30, 2026. Adjusted revenue reached C$603.7 million, up 13.8% from a year earlier. Global wealth management produced C$304.7 million in quarterly revenue, while global capital markets contributed C$286.8 million. Total client assets in wealth management rose 21.5% to C$162.3 billion. These figures suggest that the proposed restructuring is not simply a response to collapsing business activity.
Profit figures require more care. On a basis excluding specified significant items, Canaccord reported diluted earnings of C$0.43 per common share. Under International Financial Reporting Standards, however, it recorded a diluted loss of C$0.25 per common share. Those are different accounting presentations, not interchangeable measures of profitability. The contrast helps explain why valuation debates around a diversified financial firm can become complicated: its businesses may generate substantial revenue while accounting adjustments, compensation and market-sensitive operations produce less predictable headline earnings.
The Remaining Canaccord Would Have a Different Risk Profile
Selling the British wealth business would remove a significant source of recurring client-related fees. As of September 30, that operation accounted for roughly half of the firm’s C$162.3 billion in reported global wealth management client assets. Canaccord would retain other wealth operations, including C$61.0 billion in North American client assets and C$19.5 billion in Australia, alongside an international capital markets franchise that advises companies and helps them raise financing.
That mix is central to the board’s rationale. The independent special committee concluded that a smaller, less diversified public company would rely more heavily on cyclical capital markets income, which can rise sharply during active dealmaking periods and weaken when transactions slow. A private owner may have more flexibility to pursue a multiyear investment plan without the same quarterly public-market scrutiny. That is management’s case for the deal, rather than a promise that privatization will make the underlying business less risky.
Independent Directors Had to Evaluate Their Own CEO’s Offer
An offer from the company’s chief executive creates a delicate situation: the person seeking to buy the business also knows its operations from the inside. Canaccord assigned the negotiations to a special committee of independent directors chaired by lead independent director Michael Auerbach. The committee unanimously recommended the transaction, and the full board approved it unanimously with Daviau abstaining. Those steps are designed to separate the buyer’s interests from the responsibility to protect outside shareholders.
The review also included outside financial assessments. INFOR Financial prepared a formal valuation placing the common shares in a range of C$14.60 to C$15.67 as of November 15. The estimated C$15.27 consideration lies inside that range, although below its upper end. INFOR delivered fairness opinions covering the common and Series C preferred shares, while Greenhill assessed the C$7.45 component of the common-share consideration. Such opinions inform a decision; they do not eliminate uncertainty or prove that no higher offer is possible.
Shareholder Support Does Not Guarantee Approval
Canaccord says holders representing approximately 35% of outstanding common shares, including shares issuable from convertible debentures, have indicated support for the deal. That figure includes Daviau, who beneficially owns, controls or has voting rights over approximately 6.3% on the company’s stated basis. Some supporters have formal voting commitments, but it would be misleading to treat the entire 35% as an unconditional promise that the transaction will pass every required vote.
The proposed arrangement must receive at least two-thirds of votes cast by common shareholders, plus approval by a simple majority of eligible minority shareholders excluding Daviau and other required exclusions. Series C preferred shareholders must separately provide a two-thirds majority of votes cast. Their proposed consideration is C$25.30 in cash per share, plus accrued and unpaid dividends. The majority-of-the-minority requirement is particularly important because it gives unaffiliated investors a meaningful voice even when an insider has substantial existing support. Court and regulatory approvals are also required.
A 45-Day Window Leaves Room for Another Buyer
Despite the signed arrangement, Canaccord has not closed the door to competing bids. The agreement establishes a 45-day go-shop period ending December 30, 2026. During that time, the company, its independent special committee and advisers intend to actively seek alternative acquisition proposals. That process matters because it offers a market test for whether another buyer values the remaining business and the anticipated UK sale proceeds more highly than Daviau does.
There are limits to that flexibility. After the go-shop window, customary restrictions on soliciting offers apply, although the company can respond to qualifying superior proposals, subject to Daviau’s acquisition vehicle having matching rights. Canaccord could owe a C$41.6 million termination fee in certain circumstances, including accepting a superior bid. The financing for Daviau’s proposal is committed and the arrangement is not subject to a financing condition, but neither feature makes its completion certain. The next several weeks could still alter the outcome.
The Failed 2023 Buyout Is Part of the Backstory
This is not the first attempt to move Canaccord into private hands. In January 2023, a management-led group proposed acquiring the shares it did not own for C$11.25 apiece. The independent special committee opposed that price, citing an RBC Capital Markets valuation of C$12.75 to C$15.75 per share. The dispute highlighted a recurring tension in management buyouts: executives can see advantages to private ownership while outside investors question whether the price properly captures future value.
That earlier bid expired in June 2023 after substantive conditions, including regulatory approvals, had not been satisfied. No shares were acquired, and Canaccord subsequently entered a two-year standstill agreement with the management group. The new proposal arrives with a different price, a separate UK asset sale and a newly negotiated structure. Comparing C$15.27 directly with C$11.25 shows how the announced amounts differ, but it does not establish how much shareholders have gained: the company’s assets, business mix and market circumstances have changed.
What Happens Between Now and the Expected 2027 Closing
Canaccord expects a special shareholder meeting in the first quarter of 2027, with both the UK sale and the go-private transaction targeted for the first half of the year. The UK deal requires approvals that include the Financial Conduct Authority and relevant authorities in Jersey, Guernsey and the Isle of Man. The Canadian arrangement also needs shareholder approvals, the Supreme Court of British Columbia’s approval and other conditions. Until those milestones are met, the company remains publicly traded.
If the take-private closes, its common and Series C preferred shares are expected to be delisted, while Daviau and the existing leadership team would continue managing the remaining business. Regular dividends may continue before closing at the board’s discretion. There is also an important downside scenario: if the British wealth sale closes but the buyout fails, Canaccord has not promised to distribute all or any of those sale proceeds to shareholders. For investors, the story is ultimately about execution, not merely the attractive number in the headline.